These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 236357)

  • 1. The opsonic fragment of the third component of human complement (C3).
    Stossel TP; Field RJ; Gitlin JD; Alper CA; Rosen FS
    J Exp Med; 1975 Jun; 141(6):1329-47. PubMed ID: 236357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.
    Stossel TP; Alper CA; Rosen FS
    J Exp Med; 1973 Mar; 137(3):690-705. PubMed ID: 4631990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA; Dierich MP; Mūller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
    Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
    Minta JO; Man D; Movat HZ
    J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative studies of phagocytosis. Kinetic effects of cations and heat-labile opsonin.
    Stossel TP
    J Cell Biol; 1973 Aug; 58(2):346-56. PubMed ID: 4738105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the properdin-binding site in the third component of complement.
    Lambris JD; Alsenz J; Schulz TF; Dierich MP
    Biochem J; 1984 Jan; 217(1):323-6. PubMed ID: 6696726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement.
    Hostetter MK; Krueger RA; Schmeling DJ
    J Infect Dis; 1984 Nov; 150(5):653-61. PubMed ID: 6491376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.
    Gordon DL; Rice J; Finlay-Jones JJ; McDonald PJ; Hostetter MK
    J Infect Dis; 1988 Apr; 157(4):697-704. PubMed ID: 3279137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of membrane receptors for C3b and C3d in phagocytosis.
    Ehlenberger AG; Nussenzweig V
    J Exp Med; 1977 Feb; 145(2):357-71. PubMed ID: 833545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tryptic fragments of human complement factor C3.
    Eggertsen G; Hellman U; Lundwall A; Folkersen J; Sjöquist J
    Mol Immunol; 1985 Aug; 22(8):833-41. PubMed ID: 3930949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption.
    Engels W; Endert J; Van Boven CP
    J Immunol Methods; 1985 Jul; 81(1):43-53. PubMed ID: 3926902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a lamprey complement protein homologous to the third component of the mammalian complement system.
    Nonaka M; Fujii T; Kaidoh T; Natsuume-Sakai S; Nonaka M; Yamaguchi N; Takahashi M
    J Immunol; 1984 Dec; 133(6):3242-9. PubMed ID: 6491286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b).
    Gitlin JD; Rosen FS; Lachmann PJ
    J Exp Med; 1975 May; 141(5):1221-6. PubMed ID: 1168693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent effects of IgG and complement upon human polymorphonuclear leukocyte function.
    Goldstein IM; Kaplan HB; Radin A; Frosch M
    J Immunol; 1976 Oct; 117(4):1282-7. PubMed ID: 185296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.
    Sim RB; Sim E
    Biochem J; 1981 Jan; 193(1):129-41. PubMed ID: 7305917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    Bokisch VA; Müller-Eberhard HJ; Cochrane CG
    J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.